These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11018661)

  • 1. Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1.
    Bestman-Smith J; Gourde P; Désormeaux A; Tremblay MJ; Bergeron MG
    Biochim Biophys Acta; 2000 Sep; 1468(1-2):161-74. PubMed ID: 11018661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments.
    Dufresne I; Désormeaux A; Bestman-Smith J; Gourde P; Tremblay MJ; Bergeron MG
    Biochim Biophys Acta; 1999 Oct; 1421(2):284-94. PubMed ID: 10518698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes.
    Gagné JF; Désormeaux A; Perron S; Tremblay MJ; Bergeron MG
    Biochim Biophys Acta; 2002 Feb; 1558(2):198-210. PubMed ID: 11779569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B.
    Bestman-Smith J; Désormeaux A; Tremblay MJ; Bergeron MG
    AIDS; 2000 Nov; 14(16):2457-65. PubMed ID: 11101055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP).
    Atobe K; Ishida T; Ishida E; Hashimoto K; Kobayashi H; Yasuda J; Aoki T; Obata K; Kikuchi H; Akita H; Asai T; Harashima H; Oku N; Kiwada H
    Biol Pharm Bull; 2007 May; 30(5):972-8. PubMed ID: 17473445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular association and cytotoxicity of doxorubicin-loaded immunoliposomes targeted via Fab' fragments of an anti-CD74 antibody.
    Lundberg BB; Griffiths G; Hansen HJ
    Drug Deliv; 2007 Mar; 14(3):171-5. PubMed ID: 17454037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
    Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
    J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model.
    Tseng YL; Hong RL; Tao MH; Chang FH
    Int J Cancer; 1999 Mar; 80(5):723-30. PubMed ID: 10048974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo.
    Maruyama K; Takahashi N; Tagawa T; Nagaike K; Iwatsuru M
    FEBS Lett; 1997 Aug; 413(1):177-80. PubMed ID: 9287139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake.
    Moghimi M; Moghimi SM
    J Drug Target; 2008 Aug; 16(7):586-90. PubMed ID: 18686128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
    Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
    Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo.
    Peeters PA; Oussoren C; Eling WM; Crommelin DJ
    Biochim Biophys Acta; 1988 Aug; 943(2):137-47. PubMed ID: 3401475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of anti-p185HER2 immunoliposomes for cancer therapy.
    Park JW; Hong K; Carter P; Asgari H; Guo LY; Keller GA; Wirth C; Shalaby R; Kotts C; Wood WI
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1327-31. PubMed ID: 7877976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.